IntelGenx Technologies Corp.

OTC:IGXT

0.15 (USD) • At close November 27, 2023
Bedrijfsnaam IntelGenx Technologies Corp.
Symbool IGXT
Munteenheid USD
Prijs 0.14
Beurswaarde 24,452,120
Dividendpercentage 0%
52-weken bereik 0.09 - 0.27
Industrie Biotechnology
Sector Healthcare
CEO Mr. André Godin C.A., CPA, CA, CPA
Website https://www.intelgenx.com

An error occurred while fetching data.

Over IntelGenx Technologies Corp.

IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction;

Vergelijkbare Aandelen

Pineapple, Inc. logo

Pineapple, Inc.

PNPL

0.12 USD

C21 Investments Inc. logo

C21 Investments Inc.

CXXIF

0.257 USD

REMSleep Holdings, Inc. logo

REMSleep Holdings, Inc.

RMSL

0.016 USD

Cryomass Technologies Inc. logo

Cryomass Technologies Inc.

CRYM

0.071 USD

Ainos, Inc. logo

Ainos, Inc.

AIMD

0.483 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)